Cargando…
A serotonergic biobehavioral signature differentiates cocaine use disorder participants administered mirtazapine
Cocaine use disorder (CUD) patients display heterogenous symptoms and unforeseeable responses to available treatment approaches, highlighting the need to identify objective, accessible biobehavioral signatures to predict clinical trial success in this population. In the present experiments, we emplo...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076859/ https://www.ncbi.nlm.nih.gov/pubmed/35523779 http://dx.doi.org/10.1038/s41398-022-01934-w |